4 Results for "

ATPase-IN-6

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "ATPase-IN-6" in MCE Product Catalog:

Cat. No.: HY-174258
CAS No.: 3082397-26-7
Target:  

Proton Pump HIV SARS-CoV

Research Areas:  

Infection

ATPase-IN-6 is a H +/K +- ATPase inhibitor and a prazole derivative. ATPase-IN-6 has significant antiviral activity against multiple viruses, such as HIV-1 and SARS-COV2. ATPase-IN-6 can be used for antiviral infections research .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-128892
CAS No.: 1808714-73-9
Purity:  99.42%
Target:  

Autophagy

Research Areas:  

Neurological Disease

EN6 is a small-molecule in vivo autophagy activator that covalently targets cysteine 277 in the ATP6V1A subunit of the lysosomal v-ATPase. EN6-mediated modification of ATP6V1A uncouples v-ATPase from Rag, leading to inhibition of mTORC1 signalling, increased lysosomal acidification, and activation of autophagy. EN6 also scavenges TDP-43 aggregates (causative agents of frontotemporal dementia) in a lysosome-dependent manner .
loading...
    loading...
Cat. No.: HY-110042
CAS No.: 171009-07-7
Purity:  99.94%
CCT018159 is an ATP-competitive HSP90β inhibitor, with an IC50 of 3.2 μM against human HSP90β ATPase and 6.6 μM against yeast HSP90β ATPase. CCT018159 induces cell cycle arrest and apoptosis in tumor cells, and inhibits invasion and angiogenesis. CCT018159 is applicable to cancer-related research .
loading...
    loading...
Cat. No.: HY-P2657
CAS No.: 138067-14-8
Verucopeptin is a potent HIF-1 (IC50=0.22 μM) inhibitor and decreases the expression of HIF-1 target genes and HIF-1α protein levels. Verucopeptin strongly inhibits v-ATPase activity by directly targeting the v-ATPase ATP6V1G subunit but not ATP1V1B2 or ATP6V1D. Verucopeptin exhibits antitumor activity against multidrug resistance (MDR) cancers and can be used for cancer research.
loading...
    loading...